Glowing dye helps surgeons spot hidden lung cancer

NCT ID NCT03582124

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special dye, panitumumab-IRDye800, that attaches to lung cancer cells and makes them glow under a special camera during surgery. The goal is to help surgeons see and remove all cancer tissue more accurately. About 30 adults with lung cancer or lung metastases will receive the dye before their planned surgery. Researchers will check the best dose and timing, and whether the dye helps find cancer that standard methods might miss.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Panitumumab-IRDye800 (a dye attached to an antibody that targets cancer cells)
What this could lead to
If it works, this could help surgeons remove lung cancer more completely during surgery, potentially reducing the chance of leftover cancer.
What could go wrong
This is an early-phase trial with only 30 people, so it may not work as hoped. The dye could cause side effects like allergic reactions or miss some cancer cells.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Stanford University, School of Medicine

    RECRUITING

    Palo Alto, California, 94304, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.